Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient

PLoS Pathogens

Volumn 9, Issue 5, 2013, Pages

  Yukl, Steven A ^a   Boritz, Eli ^b   Busch, Michael ^c   Bentsen, Christopher ^d   Chun, Tae Wook ^e   Douek, Daniel ^b   Eisele, Evelyn ^f   Haase, Ashley ^g   Ho, Ya Chi ^f   Hütter, Gero ^h   Justement, J Shawn ^e   Keating, Sheila ^c   Lee, Tzong Hae ^c   Li, Peilin ^a   Murray, Danielle ^e   Palmer, Sarah ⁱ   Pilcher, Christopher ^j   Pillai, Satish ^a   Price, Richard W ^a   Rothenberger, Meghan ^g   Schacker, Timothy ^g   Siliciano, Janet ^f   Siliciano, Robert ^f,k   Sinclair, Elizabeth ^j   Strain, Matt ^l,m   Wong, Joseph ^a   Richman, Douglas ^l,m   Deeks, Steven G ^j   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d BIO RAD LABORATORIES   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD20 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GLYCOPROTEIN P 15095; TRANSCRIPTOME;

ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SELECTION; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LYMPH NODE BIOPSY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SIGMOIDOSCOPY; TREATMENT WITHDRAWAL; WESTERN BLOTTING;

ADULT; ALLOGRAFTS; ANTI-RETROVIRAL AGENTS; ANTIBODIES, VIRAL; DNA, VIRAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV; HIV INFECTIONS; HUMANS; RNA, VIRAL;

REPLICATION COMPETENT VIRUSES;

EID: 84878503062     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003347     Document Type: Article

References (56)

1. Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, et al. (2009) The challenge of finding a cure for HIV infection. Science 323: 1304-1307.
2. Deeks SG, Autran B, Berkhout B, Benkirane M, Cairns S, et al. (2012) Towards an HIV cure: a global scientific strategy. Nature reviews Immunology 12: 607-614.
3. Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, et al. (2009) Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. The New England journal of medicine 360: 692-698.
4. Allers K, Hutter G, Hofmann J, Loddenkemper C, Rieger K, et al. (2011) Evidence for the cure of HIV infection by CCR5Delta32/Delta32 stem cell transplantation. Blood 117: 2791-2799.
5. Symons J, Deeks S, Hutter G, Wensing A, Martin J, et al. (2012) The cure of the 'Berlin patient': why did pre-existing X4-variants not emergence after allogeneic CCR5-Δ32 SCT?. 19th International AIDS Conference. Washington, D.C.
6. Alexaki A, Liu Y, Wigdahl B, (2008) Cellular reservoirs of HIV-1 and their role in viral persistence. Current HIV research 6: 388-400.
7. Palmer S, Maldarelli F, Wiegand A, Bernstein B, Hanna GJ, et al. (2008) Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proceedings of the National Academy of Sciences of the United States of America 105: 3879-3884.
8. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, et al. (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387: 183-188.
9. Finzi D, Hermankova M, Pierson T, Carruth L, Buck C, et al. (1997) Identification of a reservoir for HIV in patients on highly active antiretroviral therapy. Science 278: 1295-1300.
10. Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, et al. (1997) Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278: 1291-1295.
11. Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, et al. (1999) Latent infection of CD4 Tcells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature Medicine 5: 512-517.
12. Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, et al. (2003) Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 9: 727-728.
13. Haase AT, Henry K, Zupancic M, Sedgewick G, Faust RA, et al. (1996) Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274: 985-989.
14. Wong JK, Gunthard HF, Havlir DV, Zhang ZQ, Haase AT, et al. (1997) Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U S A 94: 12574-12579.
15. Kuster H, Opravil M, Ott P, Schlaepfer E, Fischer M, et al. (2000) Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection. Am J Pathol 156: 1973-1986.
16. Poles MA, Boscardin WJ, Elliott J, Taing P, Fuerst MM, et al. (2006) Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals. J Acquir Immune Defic Syndr 43: 65-68.
17. Chun TW, Nickle DC, Justement JS, Meyers JH, Roby G, et al. (2008) Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. The Journal of infectious diseases 197: 714-720.
18. Yukl SA, Gianella S, Sinclair E, Epling L, Li Q, et al. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J Infect Dis 202: 1553-1561.
19. Chun TW, Murray D, Justement JS, Hallahan CW, Moir S, et al. (2011) Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy. The Journal of infectious diseases 204: 135-138.
20. Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, et al. (2003) New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 41: 4531-4536.
21. Busch MP, Glynn SA, Wright DJ, Hirschkorn D, Laycock ME, et al. (2005) Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection. Transfusion 45: 1853-1863.
22. Hatano H, Delwart EL, Norris PJ, Lee TH, Dunn-Williams J, et al. (2009) Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol 83: 329-335.
23. Yukl SA, Li P, Fujimoto K, Lampiris H, Lu CM, et al. (2011) Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter. Journal of virological methods 175: 261-265.
24. Yukl S SE, Harvill K, Gilman L, Hoh R, Hunt PW, et al. (2012) Comparison of GALT HIV RNA and DNA Levels in HIV-Infected controllers, non-controllers, and HAART-suppressed individuals; 2012 March 5-8; Seattle, Washington.
25. Durand CM, Ghiaur G, Siliciano JD, Rabi SA, Eisele EE, et al. (2012) HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy. The Journal of infectious diseases 205: 1014-1018.
26. Strain MC, Lada SF, Luong T, Rought SE, Gianella S, et al. (2013) Highly Precise Measurement of HIV DNA by Droplet Digital PCR. PloS one 8: e55943.
27. Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JM, et al. (1997) Presence of an inducible HIV latent reservoir during highly active antiretroviral therapy. PNAS 94: 13193-13197.
28. Siliciano JD, Siliciano RF, (2005) Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. Methods in molecular biology 304: 3-15.
29. Keating SM, Hanson D, Lebedeva M, Laeyendecker O, Ali-Napo NL, et al. (2012) Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation. Journal of clinical microbiology 50: 3968-3976.
30. Duong YT, Qiu M, De AK, Jackson K, Dobbs T, et al. (2012) Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS ONE 7: e33328.
31. Ndhlovu LC, Sinclair E, Epling L, Tan QX, Ho T, et al. (2010) IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery. Journal of clinical immunology 30: 681-692.
32. Fischer M, Joos B, Niederost B, Kaiser P, Hafner R, et al. (2008) Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy. Retrovirology 5: 107.
33. Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, et al. (1991) Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and-defective viral genomes. J Virol 65: 3973-3985.
34. Sanchez G, Xu X, Chermann JC, Hirsch I, (1997) Accumulation of defective viral genomes in peripheral blood mononuclear cells fo HIV infected individuals. Journal of Virology 71: 2233-2240.
35. Piatak M Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, et al. (1993) High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259: 1749-1754.
36. Eriksson S, Graf EH, Dahl V, Strain MC, Yukl SA, et al. (2013) Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies. PLoS pathogens 9: e1003174.
37. Luzuriaga K, McManus M, Catalina M, Mayack S, Sharkey M, et al. (2000) Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses. Journal of virology 74: 6984-6991.
38. Binley JM, Trkola A, Ketas T, Schiller D, Clas B, et al. (2000) The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection. The Journal of infectious diseases 182: 945-949.
39. Hare CB, Pappalardo BL, Busch MP, Karlsson AC, Phelps BH, et al. (2006) Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection. Clin Infect Dis 42: 700-708.
40. Ljungman P, Wiklund-Hammarsten M, Duraj V, Hammarstrom L, Lonnqvist B, et al. (1990) Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. The Journal of infectious diseases 162: 496-500.
41. Keele BF, Derdeyn CA, (2009) Genetic and antigenic features of the transmitted virus. Current opinion in HIV and AIDS 4: 352-357.
42. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, et al. (2009) Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. The Journal of experimental medicine 206: 1273-1289.
43. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273: 1856-1862.
44. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, et al. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86: 367-377.
45. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, et al. (1996) Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382: 722-725.
46. Biti R, Ffrench R, Young J, Bennetts B, Stewart G, et al. (1997) HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nature medicine 3: 252-253.
47. Theodorou I, Meyer L, Magierowska M, Katlama C, Rouzioux C, (1997) HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group. Lancet 349: 1219-1220.
48. O'Brien TR, Winkler C, Dean M, Nelson JA, Carrington M, et al. (1997) HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet 349: 1219.
49. Ballana E, Riveira-Munoz E, Pou C, Bach V, Parera M, et al. (2012) HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Delta32/Delta32. Immunobiology 218: 543-7.
50. Blanco J, Bosch B, Fernandez-Figueras MT, Barretina J, Clotet B, et al. (2004) High level of coreceptor-independent HIV transfer induced by contacts between primary CD4 T cells. The Journal of biological chemistry 279: 51305-51314.
51. Gorry PR, Dunfee RL, Mefford ME, Kunstman K, Morgan T, et al. (2007) Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote. Virology 362: 163-178.
52. Schmitz J, van Lunzen J, Tenner-Racz K, Grossschupff G, Racz P, et al. (1994) Follicular dendritic cells retain HIV-1 particles on their plasma membrane, but are not productively infected in asymptomatic patients with follicular hyperplasia. Journal of immunology 153: 1352-1359.
53. Smith BA, Gartner S, Liu Y, Perelson AS, Stilianakis NI, et al. (2001) Persistence of infectious HIV on follicular dendritic cells. Journal of immunology 166: 690-696.
54. Cavert W, Notermans DW, Staskus K, Wietgrefe S, Zupancic M, et al. (1997) Kinetics of Response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276: 960-964.
55. Mendoza D, Johnson SA, Peterson BA, Natarajan V, Salgado M, et al. (2012) Comprehensive analysis of unique cases with extraordinary control over HIV replication. Blood 119: 4645-4655.
56. Kumar AM, Borodowsky I, Fernandez B, Gonzalez L, Kumar M, (2007) Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction. J Neurovirol 13: 210-224.